COVID-19: implications for immunosuppression in kidney disease and transplantation

The coronavirus disease 2019 (COVID-19) pandemic poses important challenges to the care of patients with immune-mediated kidney diseases and to kidney transplant recipients. Here, we discuss the management of immunosuppression for these patients during the pandemic and suggest potential approaches t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Nephrology 2020-07, Vol.16 (7), p.365-367
Hauptverfasser:	Kronbichler, Andreas, Gauckler, Philipp, Windpessl, Martin, Il Shin, Jae, Jha, Vivekanand, Rovin, Brad H., Oberbauer, Rainer
Format:	Artikel
Sprache:	eng
Schlagworte:	692/4022/272 692/4022/272/1684 Betacoronavirus Comment Coronavirus Infections - drug therapy Coronavirus Infections - immunology Coronaviruses COVID-19 Development and progression Glomerulonephritis - drug therapy Glomerulonephritis - immunology Humans Immunology Immunosuppressive Agents - therapeutic use Immunotherapy Kidney diseases Kidney Transplantation Kidney transplants Medical colleges Medical research Medicine Medicine & Public Health Medicine, Experimental Nephrology Pandemics Pneumonia, Viral - drug therapy Pneumonia, Viral - immunology SARS-CoV-2 Transplantation of organs, tissues, etc Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The coronavirus disease 2019 (COVID-19) pandemic poses important challenges to the care of patients with immune-mediated kidney diseases and to kidney transplant recipients. Here, we discuss the management of immunosuppression for these patients during the pandemic and suggest potential approaches that could be considered in the absence of validated strategies.
ISSN:	1759-5061 1759-507X
DOI:	10.1038/s41581-020-0305-6